Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe fever with thrombocytopenia syndrome-associated encephalopathy/encephalitis.
Park SY, Kwon JS, Kim JY, Kim SM, Jang YR, Kim MC, Cho OH, Kim T, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Park SY, et al. Among authors: jang yr. Clin Microbiol Infect. 2018 Apr;24(4):432.e1-432.e4. doi: 10.1016/j.cmi.2017.09.002. Epub 2017 Sep 9. Clin Microbiol Infect. 2018. PMID: 28899841 Free article.
The First Case of Monkeypox in the Republic of Korea.
Jang YR, Lee M, Shin H, Kim JW, Choi MM, Kim YM, Lee MJ, Kim J, Na HK, Kim JY. Jang YR, et al. J Korean Med Sci. 2022 Jul 11;37(27):e224. doi: 10.3346/jkms.2022.37.e224. J Korean Med Sci. 2022. PMID: 35818706 Free PMC article.
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection.
Kim JY, Jang YR, Hong JH, Jung JG, Park JH, Streinu-Cercel A, Streinu-Cercel A, Săndulescu O, Lee SJ, Kim SH, Jung NH, Lee SG, Park JE, Kim MK, Jeon DB, Lee YJ, Kim BS, Lee YM, Kim YS. Kim JY, et al. Among authors: jang yr. Clin Ther. 2021 Oct;43(10):1706-1727. doi: 10.1016/j.clinthera.2021.08.009. Epub 2021 Aug 23. Clin Ther. 2021. PMID: 34551869 Free PMC article. Clinical Trial.
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019.
Streinu-Cercel A, Săndulescu O, Preotescu LL, Kim JY, Kim YS, Cheon S, Jang YR, Lee SJ, Kim SH, Chang I, Suh JH, Lee SG, Kim MR, Chung DR, Kim HN, Streinu-Cercel A, Eom JS. Streinu-Cercel A, et al. Among authors: jang yr. Open Forum Infect Dis. 2022 Feb 2;9(4):ofac053. doi: 10.1093/ofid/ofac053. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35295819 Free PMC article.
51 results